Advancing Cervical Cancer Prevention in India : Insights from Research and Programs
Cervical cancer is the leading cause of cancer mortality in India, accounting for 17 percent of all cancer deaths among women age 30 to 69 years. At current incidence rates, the World Health Organization (WHO) estimates that the annual burden of ne...
| Main Authors: | , , , |
|---|---|
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2014
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2013/10/19226581/advancing-cervical-cancer-prevention-india-insights-research-programs http://hdl.handle.net/10986/17850 |
| Summary: | Cervical cancer is the leading cause of
cancer mortality in India, accounting for 17 percent of all
cancer deaths among women age 30 to 69 years. At current
incidence rates, the World Health Organization (WHO)
estimates that the annual burden of new cases in India will
increase to nearly 225,000 by 2025. Despite the considerable
burden of cervical cancer morbidity and mortality in India,
there are few large-scale, organized cervical cancer
prevention programs in the country. We reviewed the research
literature and conducted interviews with individuals engaged
in research and public health program implementation to
identify important elements of cervical cancer prevention
efforts in India and implementation issues that merit
further investigation. Although primary prevention through
HPV vaccination has been endorsed by WHO, under certain
conditions, in low- and middle-income countries (LMICs), its
cost, partial efficacy and safety have been intensely
debated in India. Further research and advocacy efforts are
needed to determine the optimal strategies for its
introduction and sustained use in the country. However,
there is considerable research and programmatic evidence in
support of secondary prevention of cervical cancer through
screening and treatment. Regardless of screening approach,
research and prevention programs have underscored the
importance of ensuring strong linkages between screening,
diagnosis, and treatment services for program and cost
effectiveness. Available evidence also emphasizes that
programs that are 'women-centered,' or actively
respond to women's concerns and constraints are likely
to be the most successful. In conclusion, research and
prevention program experiences provide a strong rationale
for investments in cervical cancer prevention in India. |
|---|